Clinical Trials Directory

Trials / Unknown

UnknownNCT05537909

Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Aseptic abscess syndrome (AA) is a rare entity characterized by the occurrence of deep abscesses with no germ found. Antibiotic therapy is ineffective and they are sensitive to anti-inflammatory treatment with corticosteroids. Gut microbiota is important for the development of the immune system. In Crohn's disease which is frequently associated with AA syndrome, dysbiosis is found but could also be involved in the immune response at a distance from the gut. Stool, blood, saliva and urine samples will be taken from the patients included and their controls in the centers where they are followed. These biological samples will be transported to Clermont Ferrand using the same procedure (transporter and dry ice) where the following analyses will be performed: microbiota on stool and saliva, short chain fatty acids on stool and lymphocyte study on blood.

Detailed description

* Included patients will be adult patients meeting the diagnostic criteria for aseptic abscess syndrome described by André et al. * Controls will be adults without aseptic abscess syndrome living in the same environment as the patients, whether related to the patient or not. Patients and controls must be able to provide informed consent and be affiliated with the French Social Security system.

Conditions

Interventions

TypeNameDescription
OTHERBiological sample collectionAll patients and their controls will be asked to provide a urine, stool, saliva and blood sample during a follow-up visit. Patients will not be specifically asked to take these samples, they will be taken during a follow-up visit, during which these samples are usually already taken.

Timeline

Start date
2021-09-07
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2022-09-13
Last updated
2024-09-19

Locations

15 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05537909. Inclusion in this directory is not an endorsement.